✦ LIBER ✦

The effects of intravenous zoledronic acid in Chinese women with postmenopausal osteoporosis

✍ Scribed by Jawl-Shan Hwang; Lin-Show Chin; Jung-Fu Chen; Tzay-Shing Yang; Po-Quang Chen; Keh-Sung Tsai; Ping Chung Leung

Publisher: Springer
Year: 2010
Tongue: English
Weight: 228 KB
Volume: 29
Category: Article
ISSN: 0914-8779
DOI: 10.1007/s00774-010-0223-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of intravenous zoledronic acid p

Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1–34)] in postmenopausal osteoporosis

✍ Felicia Cosman; Erik Fink Eriksen; Chris Recknor; Paul D Miller; Núria Guañabens 📂 Article 📅 2011 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 204 KB

Respiratory complications associated wit

Respiratory complications associated with IV zoledronic acid infusion in the treatment of postmenopausal osteoporosis

✍ H. Taggart; J. Cheng; P. Archbold 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 54 KB

The Effects of Strontium Ranelate in Asi

The Effects of Strontium Ranelate in Asian Women with Postmenopausal Osteoporosis

✍ J. S. Hwang; J. F. Chen; T. S. Yang; D. J. Wu; K. S. Tsai; C. Ho; C. H. Wu; S. L 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 202 KB

The Effects of Strontium Ranelate in Asi

The Effects of Strontium Ranelate in Asian Women with Postmenopausal Osteoporosis

✍ J. S. Hwang; J. F. Chen; T. S. Yang; D. J. Wu; K. S. Tsai; C. Ho; C. H. Wu; S. L 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 94 KB

Clinical effects of strontium ranelate i

Clinical effects of strontium ranelate in women with postmenopausal osteoporosis

✍ Pierre D. Delmas 📂 Article 📅 2004 🏛 Springer-Verlag 🌐 English ⚖ 168 KB

Intravenous ibandronate injections in po

Intravenous ibandronate injections in postmenopausal women with osteoporosis: One-year results from the dosing intravenous administration study

✍ Pierre D. Delmas; Silvano Adami; Cezary Strugala; Jacob A. Stakkestad; Jean-Yves 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 185 KB

## Abstract ## Objective Although oral bisphosphonates are effective treatments for postmenopausal women with osteoporosis, oral dosing may be unsuitable for some patients. An efficacious intravenously administered bisphosphonate could be beneficial for such patients. Ibandronate, a potent nitroge